Hims & Hers Health, Inc. (HIMS) Tops Q2 EPS by 5c, Revenue Guidance Beats
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil steadies as US fuel demand concerns face Middle East supply risks
- Dollar sags after US GDP and inflation surprise, except against yen
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
Hims & Hers Health, Inc. Reports Second Quarter 2021 Financial Results
August 11, 2021 4:05 PM EDTQ2 2021 revenue grows 69% year-over-year to $60.7 million
Q2 2021 online revenue grows 75% year-over-year to $58.1 million
Exceeds Q2 2021 guidance, raises full year 2021 expectations
SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported financial results for the second quarter ending June 30, 2021.
"This was a quarter of very strong execution, as we continued to drive consistent organic revenue growth across our business, from our core... More